North Carolina News
Most Popular North Carolina Story
A bright future for Merck's NC vaccine plant
Construction hasn't even finished at Merck's new Durham, North Carolina vaccine plant and the company's already considering what to do next. The $750 million plant, which is expected to be completed Read more...
Latest Headlines
- June 17, 2011
- October 14, 2010
- April 8, 2010
- November 13, 2009
- July 31, 2009
- July 13, 2009
- February 25, 2009
- February 17, 2009
- November 25, 2008
- October 16, 2008
- April 9, 2008
- February 22, 2008
- January 10, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
